Donate Help Contact The AHA Sign In Home
American Heart Association
Arteriosclerosis, Thrombosis, and Vascular Biology
Search: search_blue_button Advanced Search
Arteriosclerosis, Thrombosis, and Vascular Biology. 2006;26:1503-1509
Published online before print May 11, 2006, doi: 10.1161/01.ATV.0000225777.58488.f2
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Data Supplement
Right arrow All Versions of this Article:
26/7/1503    most recent
01.ATV.0000225777.58488.f2v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Wang, M.
Right arrow Articles by Lakatta, E. G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Wang, M.
Right arrow Articles by Lakatta, E. G.
Related Collections
Right arrow Mechanism of atherosclerosis/growth factors
(Arteriosclerosis, Thrombosis, and Vascular Biology. 2006;26:1503.)
© 2006 American Heart Association, Inc.


Vascular Biology

Matrix Metalloproteinase 2 Activation of Transforming Growth Factor-ß1 (TGF-ß1) and TGF-ß1–Type II Receptor Signaling Within the Aged Arterial Wall

Mingyi Wang; Di Zhao; Gaia Spinetti; Jing Zhang; Li-Qun Jiang; Gianfranco Pintus; Robert Monticone; Edward G. Lakatta

From the National Institute on Aging, Baltimore, Md.

Correspondence to Mingyi Wang MD, PhD, Laboratory of Cardiovascular Science, Gerontology Research Center, NIA/NIH, 5600 Nathan Shock Dr, Baltimore, MD 21224-6825. E-mail mingyiw{at}grc.nia.nih.gov

Objective— To study matrix metalloproteinase 2 (MMP-2) effects on transforming growth factor-ß1 (TGF-ß1) activation status and downstream signaling during arterial aging.

Methods and Results— Western blotting and immunostaining showed that latent and activated TGF-ß1 are markedly increased within the aorta of aged Fisher 344 cross-bred Brown Norway (30 months of age) rats compared with adult (8 months of age) rats. Aortic TGF-ß1–type II receptor (TßRII), its downstream molecules p-similar to mad-mother against decapentaplegic (SMAD)2/3 and SMAD4, fibronectin, and collagen also increased with age. Moreover, TGF-ß1 staining is colocalized with that of activated MMP-2 within the aged arterial wall and vascular smooth muscle cell (VSMC) in vitro, and this physical association was confirmed by coimmunoprecipitation. Incubation of young aortic rings ex vivo or VSMCs in vitro with activated MMP-2 enhanced active TGF-ß1, collagen, and fibronectin expression to the level of untreated old counterparts, and this effect was abolished via inhibitors of MMP-2. Interestingly, in old untreated rings or VSMCs, the increased TGF-ß1, fibronectin, and collagen were also substantially reduced by inhibition of MMP-2.

Conclusions— Active TGF-ß1, its receptor, and receptor-mediated signaling increase within the aortic wall with aging. TGF-ß1 activation is dependent, in part at least, by a concomitant age-associated increase in MMP-2 activity. Thus, MMP-2–activated TGF-ß1, and subsequently TßRII signaling, is a novel molecular mechanism for arterial aging.

We analyzed MMP-2 effects on TGF-ß1 activation status and downstream signaling during age-associated arterial remodeling. MMP-2 increased TGF-ß1 activity, collagen, and fibronectin within aortic rings or VSMCs from young rats to the levels that occur in old animals. All of these effects are substantially reduced by inhibition of MMP-2.


Key Words: aging • metalloproteinases • TGF-ß1 signaling • arterial remodeling




This article has been cited by other articles:


Home page
Cancer Res.Home page
D. C. Lee, Y. K. Kang, W. H. Kim, Y. J. Jang, D. J. Kim, I. Y. Park, B. H. Sohn, H. A. Sohn, H. G. Lee, J. S. Lim, et al.
Functional and Clinical Evidence for NDRG2 as a Candidate Suppressor of Liver Cancer Metastasis
Cancer Res., June 1, 2008; 68(11): 4210 - 4220.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
S. Delbosc, M. Glorian, A.-S. Le Port, G. Bereziat, M. Andreani, and I. Limon
The Benefit of Docosahexanoic Acid on the Migration of Vascular Smooth Muscle Cells Is Partially Dependent on Notch Regulation of MMP-2/-9
Am. J. Pathol., May 1, 2008; 172(5): 1430 - 1440.
[Abstract] [Full Text] [PDF]


Home page
J. Lipid Res.Home page
C.-J. Liang, H. E. Ives, C.-M. Yang, and Y.-H. Ma
20-HETE inhibits the proliferation of vascular smooth muscle cells via transforming growth factor-
J. Lipid Res., January 1, 2008; 49(1): 66 - 73.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
K. M. Sheridan, M. J. Ferguson, M. R. Distasi, F. A. Witzmann, M. C. Dalsing, S. J. Miller, and J. L. Unthank
Impact of genetic background and aging on mesenteric collateral growth capacity in Fischer 344, Brown Norway, and Fischer 344 x Brown Norway hybrid rats
Am J Physiol Heart Circ Physiol, December 1, 2007; 293(6): H3498 - H3505.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
R. C.M. Siow and A. T. Churchman
Adventitial growth factor signalling and vascular remodelling: Potential of perivascular gene transfer from the outside-in
Cardiovasc Res, September 1, 2007; 75(4): 659 - 668.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
M. Wang, J. Zhang, L.-Q. Jiang, G. Spinetti, G. Pintus, R. Monticone, F. D. Kolodgie, R. Virmani, and E. G. Lakatta
Proinflammatory Profile Within the Grossly Normal Aged Human Aortic Wall
Hypertension, July 1, 2007; 50(1): 219 - 227.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
G. Gavazzi, C. Deffert, C. Trocme, M. Schappi, F. R. Herrmann, and K.-H. Krause
NOX1 Deficiency Protects From Aortic Dissection in Response to Angiotensin II
Hypertension, July 1, 2007; 50(1): 189 - 196.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
M. Ruiz-Ortega, J. Rodriguez-Vita, E. Sanchez-Lopez, G. Carvajal, and J. Egido
TGF-{beta} signaling in vascular fibrosis
Cardiovasc Res, May 1, 2007; 74(2): 196 - 206.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
R. Khan, A. Agrotis, and A. Bobik
Understanding the role of transforming growth factor-{beta}1 in intimal thickening after vascular injury
Cardiovasc Res, May 1, 2007; 74(2): 223 - 234.
[Abstract] [Full Text] [PDF]